CompanyPrivateBeaverton, OR

Trace Biosciences Inc

SEC EDGAR ClinicalTrials.gov

DAug 12Latest SEC filing

Form DAug 12$8.3M sold

August 2026

Trace Biosciences files Form D covering $16.2 million equity offering

Aug 12FinancingTrace Biosciences Inc